Aricate Formulations Private Limited
About Aricate Formulations Private Limited
Data last updated:
Aricate Formulations Private Limited is a private limited company based in Zirakpur, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304PB2018PTC048754.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Bhayana and Umesh Kalra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO – 6 Wadhawa Nagar Near Hotel Sunpark, Zirakpur, Punjab, India – 140603.
As per MCA filings, the company has open charges of ₹5.88 Cr on record.
Company details
Contact details
Aricate Formulations Private Limited's registered office is in Zirakpur, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO – 6 Wadhawa Nagar Near Hotel Sunpark, Zirakpur, Punjab, India – 140603
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aricate Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aricate Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Aricate Formulations Private Limited
FY 2025 filings availableAricate Formulations Private Limited reported revenue of ₹400 for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹400 | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Aricate Formulations Private Limited, buy the company report.
Board of directors of Aricate Formulations Private Limited
Aricate Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Bhayana | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
| Umesh Kalra Also directs: Gallberry Formulations Private Limited, Arlak Biotech Private Limited, Magicdose Private Limited and 5 more | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
Auditor
Aricate Formulations Private Limited is audited by JAIN MITTAL CHAUDHARY & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN MITTAL CHAUDHARY & ASSOCIATES | FY 2020 | 015140N |
Shareholding
The shareholding of Aricate Formulations Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aricate Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jun 2023 | 100761914 | Hdfc Bank Limited | ₹5.88 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Aricate Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aricate Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aricate Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aricate Formulations Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Nitin Bhayana was appointed as Director on 12 Dec 2018.
Frequently asked questions
Aricate Formulations is an active private limited company based in Zirakpur, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U24304PB2018PTC048754.
Aricate Formulations has 2 current directors:
- Nitin Bhayana - Director
- Umesh Kalra - Director
The latest financial statements of Aricate Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Aricate Formulations is U24304PB2018PTC048754. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aricate Formulations was incorporated on 12 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
Nitin Bhayana was appointed as Director on 12 Dec 2018. Umesh Kalra was appointed as Director on 12 Dec 2018.
The registered office of Aricate Formulations is at SCO – 6 Wadhawa Nagar Near Hotel Sunpark, Zirakpur, Punjab, India – 140603.
Aricate Formulations operates in the pharma industry, in the drug formulation and development segment.
Aricate Formulations has open charges of ₹5.88 Cr and no satisfied charges on record as per latest MCA filings.
Aricate Formulations can be reached at its registered office: SCO – 6 Wadhawa Nagar Near Hotel Sunpark, Zirakpur, Punjab, India – 140603.